Literature DB >> 23237043

Peripheral neuropathy and quality of life of adults living with HIV/AIDS in the Rulindo district of Rwanda.

Juvenal Biraguma1, Anthea Rhoda.   

Abstract

Although the life expectancy of people living with HIV/AIDS (PLWH) has increased in the past years, they could experience secondary illness such as peripheral neuropathy (PN). Therefore, they need to adapt to chronic disablement which could affect their quality of life (QoL). The research that informed this article aimed at determining the prevalence of PN among adults living with HIV/AIDS and attending the outpatients' clinic at Rutongo Hospital in the Rulindo district of Rwanda. Another aim was to determine these patients' QoL. A cross-sectional descriptive quantitative research design was used. A time-constrained method was used to sample 185 adults living with HIV/AIDS and attending the outpatients' clinic at Rutongo Hospital. The subjective PN screen and the World Health Organization Quality of Life Scale Brief Version were used to collect the data. Data were analysed using the Statistical Package for the Social Sciences. Student's t-test and one-way analysis of variance were performed to determine if significant differences existed between QoL scores in participants with and without PN symptoms. The results indicated that 40.5% of respondents experienced PN. QoL in participants with PN showed significantly lower scores in the physical (p = 0.013) and psychological (p = 0.020) domains when compared with those who did not have PN. These results indicate a high prevalence of neuropathy among PLWH attending the outpatients' clinic at Rutongo Hospital. In addition, patients with neuropathy had lower QoL scores in the physical and psychological domains than those without neuropathy symptoms. The management of PLWH should therefore include interventions to optimise QoL as well as screening for neuropathy symptoms so that sufferers can liaise with their medical providers to find medical and supportive therapies that could assist them.

Entities:  

Mesh:

Year:  2012        PMID: 23237043     DOI: 10.1080/17290376.2012.683582

Source DB:  PubMed          Journal:  SAHARA J        ISSN: 1729-0376


  11 in total

1.  Peripheral neuropathy in HIV patients in sub-Saharan Africa failing first-line therapy and the response to second-line ART in the EARNEST trial.

Authors:  Alejandro Arenas-Pinto; Jennifer Thompson; Godfrey Musoro; Hellen Musana; Abbas Lugemwa; Andrew Kambugu; Aggrey Mweemba; Dickens Atwongyeire; Margaret J Thomason; A Sarah Walker; Nicholas I Paton
Journal:  J Neurovirol       Date:  2015-08-25       Impact factor: 2.643

2.  Distal Sensory Peripheral Neuropathy in Human Immunodeficiency Virus Type 1-Positive Individuals Before and After Antiretroviral Therapy Initiation in Diverse Resource-Limited Settings.

Authors:  Alyssa C Vecchio; Christina M Marra; Jeffrey Schouten; Hongyu Jiang; Johnstone Kumwenda; Khuanchai Supparatpinyo; James Hakim; Ned Sacktor; Thomas B Campbell; Srikanth Tripathy; Nagalingeswaran Kumarasamy; Alberto La Rosa; Breno Santos; Marcus T Silva; Cecilia Kanyama; Cindy Firnhaber; Mina C Hosseinipour; Rosie Mngqibisa; Colin Hall; Paola Cinque; Kevin Robertson
Journal:  Clin Infect Dis       Date:  2020-06-24       Impact factor: 9.079

3.  Racial and socioeconomic disparities in the symptom reporting of persons living with HIV.

Authors:  Rebecca Schnall; Karolynn Siegel; Haomiao Jia; Susan Olender; Sabina Hirshfield
Journal:  AIDS Care       Date:  2018-01-22

4.  The reliability of the modified lower extremity functional scale among adults living with HIV on antiretroviral therapy, in Rwanda, Africa.

Authors:  D K Tumusiime; A Stewart; F W D Venter; E Musenge
Journal:  SAHARA J       Date:  2014

5.  Prevalence of peripheral neuropathy and its associated demographic and health status characteristics, among people on antiretroviral therapy in Rwanda.

Authors:  David Kabagema Tumusiime; Francois Venter; Eustasius Musenge; Aimee Stewart
Journal:  BMC Public Health       Date:  2014-12-19       Impact factor: 3.295

6.  Development, Validation, and Field-Testing of an Instrument for Clinical Assessment of HIV-Associated Neuropathy and Neuropathic Pain in Resource-Restricted and Large Population Study Settings.

Authors:  Yohannes W Woldeamanuel; Peter R Kamerman; Demetri G A Veliotes; Tudor J Phillips; David Asboe; Marta Boffito; Andrew S C Rice
Journal:  PLoS One       Date:  2016-10-20       Impact factor: 3.240

7.  Peripheral neuropathy in HIV-infected and uninfected patients in Rakai, Uganda.

Authors:  Deanna Saylor; Gertrude Nakigozi; Noeline Nakasujja; Kevin Robertson; Ronald H Gray; Maria J Wawer; Ned Sacktor
Journal:  Neurology       Date:  2017-07-05       Impact factor: 9.910

8.  Prevalence and clinical characteristics associated with peripheral neuropathy amongst persons on HAART in Busia County, Kenya.

Authors:  John N Mukoma; Joseph M Matheri; Nassib Tawa
Journal:  S Afr J Physiother       Date:  2020-08-25

9.  Health-related quality of life and associated factors in adults living with HIV in Rwanda.

Authors:  Juvenal Biraguma; Eugene Mutimura; José M Frantz
Journal:  SAHARA J       Date:  2018-12

10.  The role of physiotherapy in the treatment of HIV-related sensory neuropathy: The perceptions and referral practices of physicians.

Authors:  Tania Steyl; Felista T Shayo
Journal:  S Afr J Physiother       Date:  2015-11-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.